Literature DB >> 2207500

The effects of reported Ca2+ sensitisers on the rates of Ca2+ release from cardiac troponin C and the troponin-tropomyosin complex.

S J Smith1, P J England.   

Abstract

1. The calcium sensitivity of force production of cardiac muscle fibres is altered by certain drugs. The sites of action of three such compounds (pimobendan, sulmazole, isomazole) within the myofibril have been investigated. Calmodulin antagonists, perhexilene and bepridil, which have been shown to alter the calcium dependence of myofibrillar ATPase activity and oxmetidine, an H2-receptor antagonist which binds to calmodulin, were also studied. 2. The rates of dissociation of calcium from both the regulatory and high affinity sites on bovine isolated cardiac troponin C (cTnC) were measured in a stopped-flow fluorimeter. The rates of dissociation were found to be 136.5 +/- 16 s-1 and 1.3 +/- 0.20 s-1 (mean +/- s.e.mean, n = 11 determinations; conditions: 100 mM KCl, 10 mM MOPS, 3 mM MgCl2, 0.1 mM dithriothreitol, pH 7.0, 15 degrees C). Sulmazole, isomazole and perhexiline (final concentration of 50 microM) had no effect on the rate of Ca2+ dissociation from the regulatory Ca2+ site, indicating that these compounds do not act on cTnC directly. 3. The rate of dissociation of Ca2+ from the regulatory site was slightly reduced (approximately 20%) by pimobendan (50 and 100 microM) and was somewhat increased by oxmetidine (28% at 100 microM). 4. Bepridil (25 microM) reduced the rate of dissociation by 50%, indicating a direct effect of bepridil on TnC. 5. Sulmazole, isomazole, perhexiline, pimobendan (50 microM) and bepridil (25 microM) were without effect on the rate of dissociation of Ca2+ from the high affinity Ca2+/Mg2+ sites. Oxmetidine caused 24% decrease in the rate of Ca2+ dissociation from these sites. 6. The rate of dissociation of Ca2+ from the regulatory site on the complex of troponin-tropomyosin (TnTm) was measured. Sulmazole and pimobendan (50 microM) were without effect on the rate of dissociation of Ca2+ from the regulatory site in the protein complex, and isomazole (50 microM) caused only a slight reduction (23%). Perhexiline (50 microM) or bepridil (10 microM) reduced the rate of Ca2 dissociation by about 50%. The rate of dissociation of Ca2+ from the high affinity Ca2 +/Mg2 + sites was not altered by sulmazole, isomazole, or pimobendan (50 microM), but was decreased - 35% by perhexiline (50 microM) or bepridil (10 microM).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2207500      PMCID: PMC1917594          DOI: 10.1111/j.1476-5381.1990.tb14092.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  New cardiotonic agents--a promising approach for treatment of heart failure.

Authors:  B Wetzel; N Hauel
Journal:  Trends Pharmacol Sci       Date:  1988-05       Impact factor: 14.819

2.  Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.

Authors:  H S Ahn; D Eardley; R Watkins; N Prioli
Journal:  Biochem Pharmacol       Date:  1986-04-01       Impact factor: 5.858

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Regulation and kinetics of the actin-myosin-ATP interaction.

Authors:  R S Adelstein; E Eisenberg
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

5.  A fluorescence stopped flow analysis of Ca2+ exchange with troponin C.

Authors:  J D Johnson; S C Charlton; J D Potter
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

Review 6.  Calmodulin plays a pivotal role in cellular regulation.

Authors:  W Y Cheung
Journal:  Science       Date:  1980-01-04       Impact factor: 47.728

7.  Phosphorylation of cardiac troponin by cyclic adenosine 3':5'-monophosphate-dependent protein kinase.

Authors:  J T Stull; J E Buss
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

8.  Protein binding properties of some histamine H2 antagonists: a 1H nuclear magnetic resonance study of antihistamine-calmodulin interactions.

Authors:  D G Reid
Journal:  Biochim Biophys Acta       Date:  1986-04-08

9.  Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone.

Authors:  J C Rüegg; G Pfitzer; D Eubler; C Zeugner
Journal:  Arzneimittelforschung       Date:  1984

10.  Stimulation of cardiac myofilament force, ATPase activity and troponin C Ca++ binding by bepridil.

Authors:  R J Solaro; P Bousquet; J D Johnson
Journal:  J Pharmacol Exp Ther       Date:  1986-08       Impact factor: 4.030

View more
  5 in total

1.  A quantitative analysis of cardiac myocyte relaxation: a simulation study.

Authors:  S A Niederer; P J Hunter; N P Smith
Journal:  Biophys J       Date:  2005-12-09       Impact factor: 4.033

2.  Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.

Authors:  S Antila; J Eha; M Heinpalu; L Lehtonen; I Loogna; A Mesikepp; U Planken; E P Sandell
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

3.  A computational and experimental approach to investigate bepridil binding with cardiac troponin.

Authors:  Jayson F Varughese; Tamatha Baxley; Joseph M Chalovich; Yumin Li
Journal:  J Phys Chem B       Date:  2011-02-18       Impact factor: 2.991

Review 4.  Pimobendan. A review of its pharmacology and therapeutic potential in congestive heart failure.

Authors:  A Fitton; R N Brogden
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

5.  Probing the mechanism of cardiovascular drugs using a covalent levosimendan analog.

Authors:  Sandra E Pineda-Sanabria; Ian M Robertson; Yin-Biao Sun; Malcolm Irving; Brian D Sykes
Journal:  J Mol Cell Cardiol       Date:  2016-02-04       Impact factor: 5.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.